DNIB Unwind, Inc.
(Other OTC/NBB : BIND)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.84%201.151.2%$533.73m
GILDGilead Sciences, Inc.
4.14%75.790.9%$478.79m
BIIBBiogen Inc.
2.34%336.081.3%$393.64m
CELGCelgene Corporation
2.43%83.821.2%$347.43m
ILMNIllumina, Inc.
3.21%323.463.5%$307.20m
REGNRegeneron Pharmaceuticals, Inc.
4.90%396.052.6%$239.68m
ALXNAlexion Pharmaceuticals, Inc.
4.57%127.042.0%$224.91m
VRTXVertex Pharmaceuticals Incorporated
3.81%184.421.9%$218.51m
SRPTSarepta Therapeutics, Inc.
4.53%137.2916.4%$178.87m
AAgilent Technologies, Inc.
2.39%67.201.5%$161.25m
BMRNBioMarin Pharmaceutical Inc.
6.20%105.624.4%$143.77m
LGNDLigand Pharmaceuticals Incorporated
5.02%210.1123.3%$121.15m
VKTXViking Therapeutics, Inc.
4.10%14.780.9%$116.61m
NKTRNektar Therapeutics
1.63%49.885.6%$110.83m
EXASExact Sciences Corporation
2.25%67.2525.3%$105.34m

Company Profile

DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Cambridge, MA.